Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-25-328909

Chief Scientific Officer sold 1,345 shares at $10.01 ($13,463)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-19 Sale : show line 1 in the form 10b5-1 −1,345 $10.01 $13,463 132,635 D
Open-market sales · 1,345 sh · avg $10.01 · $13,463
Loading xslF345X05/ownership.xml…